A company car orlistato infarmed Late Thursday night, First Manhattan won what had become anincreasingly bitter proxy battle at Vivus, where it is thelargest shareholder with a 9.9 percent stake. First Manhattangained a six-person majority on a newly reconstituted board andthe right to bring in a new chief executive to run thedrugmaker.
